This paper presents a quantitative study of the position of the Golgi apparatus in the developing chick myocardium between stages 8+ and 13+ . In addition we have studied the effects of colchicine on the position and structure of the Golgi apparatus. During the formation of the heart tube and loop the position of the Golgi apparatus in the myocytes situated in the vicinity of the dorsal mesocardium is related to that found in the cells of the precardiac mesoderm, but it is completely different from that found in the bulk of myocytes of the heart tube and loop. The position of the Golgi apparatus in both pre- and myocardial cells shows clear significative patterns of polarity. The possible significance of the Golgi apparatus polarity is discussed. After colchicine treatment microtubules disappear, the Golgi apparatus loses its polarization and vacuoles filled with amorphous material and/or collagen fibrils are observed. A possible role of the microtubular system in the maintenance of the structure and polarity of the Golgi apparatus and in the intracytoplasmic transport of the cardiac jelly materials is proposed.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.